Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.80
-0.27 (-1.58%)
Oct 26, 2026, 10:31 AM EDT - Market open
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.11 billion as of October 26, 2026. It is the 9,410th most valuable company in the world and the 2,159th biggest in the United States. Its market cap has increased by 18.76% in one year.
Market Cap
1.11B
Enterprise Value
615.61M
1-Year Change
18.76%
Global Rank
Country Rank
#2,159 United States
Category
ChartMarket Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.11B, an increase of 19.32%. That is a compound annual growth rate of 8.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.11B | 20.58% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verastem | 1.22B |
| Alpha Tau Medical | 1.22B |
| Omeros | 1.20B |
| Kardigan | 1.20B |
| Syndax Pharmaceuticals | 1.20B |
| Silence Therapeutics | 1.18B |
| Avalyn Pharma | 1.15B |
| Seaport Therapeutics | 1.10B |